Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Macular Degeneration, Wet”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Not Yet RecruitingNCT07764965
What this trial is testing

Evaluation of PAN-90806 Eye Drops in Healthy Subjects

Who this might be right for
Wet Age Related Macular DegenerationNeovascular (Wet) Age-Related Macular Degeneration
Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd. 20
Large-scale testing (Phase 3)Study completedNCT00321997
What this trial is testing

A Clinical Trial to Explore Safety and Efficacy of Different Doses of Pegaptanib Sodium, Compared to Sham, in Patients With Wet AMD.

Who this might be right for
Age-Related Macular Degeneration
Eyetech Pharmaceuticals 540
Testing effectiveness (Phase 2)Study completedNCT03345082
What this trial is testing

A Dose Ranging Study of OPT-302 With Ranibizumab in Neovascular (Wet) AMD

Who this might be right for
Neovascular Age-related Macular Degeneration
Opthea Limited 366
Not applicableStudy completedNCT01666821
What this trial is testing

A Population-based Study of Macular Choroidal Neovascularization in a Chinese Population

Who this might be right for
Geographic AtrophyWet Macular DegenerationRetinal Drusen
Shanghai University of Traditional Chinese Medicine 59
Early research (Phase 1)Ended earlyNCT01086761
What this trial is testing

Study of MP0112 Intravitreal Injection in Patients With Wet Age Related Macular Degeneration

Who this might be right for
Wet Age-Related Macular Degeneration
Allergan 32
Not applicableStudy completedNCT00656903
What this trial is testing

High Speed Indocyanine Green Angiography Findings in Ranibizumab Treatment for Wet Age-related Macular Degeneration

Who this might be right for
Macular Degeneration
National Eye Institute (NEI) 75
Testing effectiveness (Phase 2)Ended earlyNCT03452527
What this trial is testing

Open-Label Study of Intravitreal ICON-1 in Patients With Choroidal Neovascularization Secondary to Age-related Macular Degeneration (AMD)

Who this might be right for
Choroidal NeovascularizationWet Macular Degeneration
Iconic Therapeutics, Inc. 15
Early research (Phase 1)Study completedNCT02022540
What this trial is testing

Phase 1 Study of Topical Ocular PAN-90806 for Neovascular AMD

Who this might be right for
Age-Related Macular Degeneration (AMD)
PanOptica, Inc. 50
Post-approval studies (Phase 4)Study completedNCT02581891
What this trial is testing

Managing Neovascular (Known as "Wet") Age-related Macular Degeneration Over 2 Years Using Different Treatment Schedules of 2 mg Intravitreal Aflibercept Injected in the Eye

Who this might be right for
Macular Degeneration
Bayer 287
Early research (Phase 1)UnknownNCT04468997
What this trial is testing

The Study of Drug 601 in Patients With Wet Age-related Macular Degeneration (wAMD)

Who this might be right for
Wet Age-related Macular Degeneration
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. 67
Testing effectiveness (Phase 2)Study completedNCT05275205
What this trial is testing

Safety, Tolerability, and Efficacy Study of UBX1325 in Patients With Neovascular Age-Related Macular Degeneration (ENVISION)

Who this might be right for
Neovascular Age-related Macular Degeneration
Unity Biotechnology, Inc. 51
Not applicableStudy completedNCT03290794
What this trial is testing

Structured Post-marketing Surveillance to Collect the Safety Data of Intravitreal Aflibercept Injection (IVT-AFL) in Patients of Wet Age-related Macular Degeneration During Real World Clinical Practice

Who this might be right for
Wet Age-related Macular Degeneration
Bayer 100
Early research (Phase 1)Study completedNCT02543229
What this trial is testing

Study Evaluating the Safety, Pharmacokinetics and Pharmacodynamics of OPT-302 With or Without Lucentis™ in Patients With Wet AMD

Who this might be right for
Eye DiseasesMacular DegenerationRetinal Diseases+2 more
Opthea Limited 51
Very early researchNot Yet RecruitingNCT06888492
What this trial is testing

To Evaluate the Safety and Preliminary Efficacy of Intravitreal EXG202 Injection in Patients with Wet (neovascular) Age-related Macular Degeneration (wAMD)

Who this might be right for
Wet Age-related Macular Degeneration (wAMD)Wet Age-related Macular Degeneration
Guangzhou Jiayin Biotech Ltd 8
Very early researchNot Yet RecruitingNCT07728981
What this trial is testing

Biomarkers, Effectiveness, and Safety of Aflibercept 8mg Modified Fixed Dose Regimen in Treatment-Naïve nAMD Patients

Who this might be right for
Neovascular Age-Related Macular Degeneration (nAMD) Wet AMD
Tianjin Medical University Eye Hospital 49
Large-scale testing (Phase 3)Study completedNCT05345236
What this trial is testing

Compare QL1207 to Eylea® in Subjects With Wet Age-related Macular Degeneration (wAMD)

Who this might be right for
Wet Age-related Macular Degeneration
Qilu Pharmaceutical Co., Ltd. 366
Not applicableLooking for participantsNCT06859515
What this trial is testing

A Long-term Follow up Study of EXG102-031 in Participants With wAMD

Who this might be right for
Wet Age-related Macular Degeneration
Guangzhou Jiayin Biotech Ltd 42
Testing effectiveness (Phase 2)Study completedNCT04126317
What this trial is testing

Safety, Tolerability, and Efficacy of Aflibercept in Patients With Neovascular Age-Related Macular Degeneration

Who this might be right for
Neovascular (Wet) Age-Related Macular Degeneration
Regeneron Pharmaceuticals 106
Not applicableStudy completedNCT03939195
What this trial is testing

OCTA (Optical Coherence Angiography Tomography) Versus Structural OCT(Optical Coherence Tomography) in Neovascular AMD (Age Macular Degeneration)

Who this might be right for
Macular Degeneration Exudative Eye LeftMacular Degeneration Exudative Eye Right
Centre Hospitalier Intercommunal Creteil 130
Post-approval studies (Phase 4)UnknownNCT00813891
What this trial is testing

Efficacy of Ranibizumab in Combination With Photodynamic Therapy for Wet Age-Related Macular Degeneration

Who this might be right for
Macular DegenerationVisual Acuity
McGill University Health Centre/Research Institute of the McGill University Health Centre 180
Next Page